会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明授权
    • Pharmaceutical compositions and methods for use
    • 药物组合物和使用方法
    • US06441006B2
    • 2002-08-27
    • US09317321
    • 1999-05-24
    • Gary Maurice DullJared Miller WagnerSrishailkumar B. HadimaniMichael B. Consilvio
    • Gary Maurice DullJared Miller WagnerSrishailkumar B. HadimaniMichael B. Consilvio
    • A61K3144
    • C07D213/65A61K31/138A61K31/44A61K31/4406
    • Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof aryloxyalkylamines, including pyridyloxylalkylamines and phenoxyalkylamines. Exemplary compounds include dimethyl(2-(3-pyridyloxy)ethylamine, dimethyl(4-(3-pyridyloxy)butyl)amine, 2-(3-pyridyloxy)ethylamine, 4-(3-pyridyloxy)butylamine, methyl(3-(5-methoxy-3-pyridyloxy)propyl)amine, ethyl(3-(3-pyridyloxy)propyl)amine, methyl(2-(3-pyridyloxy)ethyl)amine, methyl(3-(6-methyl(3-pyridyloxy))propyl)amine, (3-(3-methoxyphenoxy)propyl)methylamine, (3-(5-chloro(3-pyridyloxy))-1-methylpropyl)methylamine, dimethyl(3-(3-pyridyloxy)propyl)amine, 3-(3-pyridyloxy)propylamine, methyl(4-(3-pyridyloxy)butyl)amine, 3-(5-chloro-3-pyridyloxy)propylamine, methyl(3-(5-isopropoxy-3-pyridyloxy)propyl)amine, (3-(5-chloro(3-pyridyloxy))propyl)methylamine, methyl(3-(5-(phenylmethoxy)(3-pyridyloxy))propyl)amine, methyl(3-(2-methyl(3-pyridyloxy))propyl)amine, (methylethyl)(3-(3-pyridyloxy)propyl)amine, benzyl(3-(3-pyridyloxy)propyl)amine, cyclopropyl(3-(3-pyridyloxy)-propyl)amine, methyl(1-methyl-3-(3-pyridyloxy)propyl)amine, methyl(3-(3-nitrophenoxy)propyl)amine, 1-(3-chloropropoxy)-3-nitrobenzene, (3-(3-aminophenoxy)propyl)methylamine, dimethyl(3-(3-(methylamino)-propoxy)phenyl)amine, methyl(3-tricyclo[7.3.1.0 ]tridec-2-yloxypropyl)amine, (3-benzo[3,4-d]1,3-dioxolan-5-yloxypropyl)methylamine, 3-(4-piperidinyloxy)pyridine and 3-((3S)-3-pyrrolidinyloxy)pyridine.
    • 通过向需要的患者施用芳氧基烷基胺(包括吡啶氧基烷基胺和苯氧基烷基胺)来治疗易患或患有病症和障碍的患者,例如中枢神经系统疾病。 示例性化合物包括二甲基(2-(3-吡啶基氧基)乙胺,二甲基(4-(3-吡啶基氧基)丁基)胺,2-(3-吡啶氧基)乙胺,4-(3-吡啶氧基)丁胺,(3- (3-(3-吡啶氧基)丙基)胺,(2-(3-吡啶氧基)乙基)胺,(3-(6-甲基-3-吡啶氧基)丙基) )丙基)胺,(3-(3-甲氧基苯氧基)丙基)甲基胺,(3-(5-氯(3-吡啶氧基))-1-甲基丙基)甲胺,二甲基(3-(3-吡啶氧基)丙基) ,3-(3-吡啶氧基)丙胺,甲基(4-(3-吡啶氧基)丁基)胺,3-(5-氯-3-吡啶氧基)丙胺,(3-(5-异丙氧基-3-吡啶氧基)丙基 )胺,(3-(5-氯(3-吡啶氧基))丙基)甲胺,(3-(5-(苯基甲氧基)(3-吡啶氧基) - 丙基)胺,(甲基乙基)(3-(3-吡啶氧基)丙基)胺,苄基(3-(3-吡啶氧基)丙基)胺,环丙基(3-(3-吡啶氧基) 甲基(1-甲基-3-(3-吡啶氧基)丙基)胺,(3-(3-硝基苯氧基)丙基)甲基胺,1-(3-氯丙氧基)-3-硝基 苯,(3-(3-氨基苯氧基)丙基)甲基胺,二甲基(3-(3-(甲基氨基)丙氧基)苯基)胺,(3-三环[7.3.1.0 5,133] (3-苯并[3,4-d] 1,3-二氧戊环-5-基氧基丙基)甲胺,3-(4-哌啶基氧基)吡啶和3 - ((3S)-3-吡咯烷基氧基)吡啶。